Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma

被引:14
作者
Strothmeyer, Anna-Maria [1 ]
Papaioannou, Dimitrios [1 ]
Duehren-von Minden, Marcus [1 ]
Navarrete, Marcelo [1 ]
Zirlik, Katja [1 ]
Heining-Mikesch, Kristina [1 ]
Veelken, Hendrik [1 ]
机构
[1] Univ Med Ctr Freiburg, Dept Hematol Oncol, Freiburg, Germany
关键词
COMPLEX CLASS-I; B-CELLS; IMMUNE-RESPONSES; VACCINATION; PEPTIDES; EXPRESSION; FREQUENCY; DISEASE; INDUCE; GENES;
D O I
10.1182/blood-2010-02-270199
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Active immunization with the idiotype of follicular lymphoma induces tumor-specific immunity. T cells induced in vivo by idiotype vaccination recognize human leukocyte antigen (HLA)-restricted hypervariable but not conserved idiotype peptides. We hypothesized that idiotype-directed T-cell immunity occurs naturally and performed a reverse immunology analysis of idiotype HLA binding in 39 follicular lymphoma patients. For every idiotype, the sum of HLA-A or -B binding scores of the 20 highest-scoring peptides was calculated for all 39 HLA types through the BIMAS algorithm. The idiotype sum score of every patient's lymphoma was compared on the respective patient's HLA type to the mean of the sum scores of the remaining 38 idiotypes. Autologous idiotypes had lower immunogenicity than allogeneicidiotypes. Differentialimmuno-genicity resided predominantly in all 3 complementarity-determining regions rather than in framework peptides. Idiotype immunogenicity was not changed by somatic hypermutation. These findings indicate T cell-mediated immunosurveillance of follicular lymphoma directed specifically against individual idiotype epitopes. (Blood. 2010; 116(10):1734-1736)
引用
收藏
页码:1734 / 1736
页数:3
相关论文
共 25 条
[1]
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma [J].
Ai, Weiyun Z. ;
Tibshirani, Robert ;
Taidi, Behnaz ;
Czerwinski, Debra ;
Levy, Ronald .
BLOOD, 2009, 113 (23) :5743-5746
[2]
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells [J].
Ai, Weiyun Z. ;
Hou, Ling-Zhou ;
Zeiser, Robert ;
Czerwinski, Debra ;
Negrin, Robert S. ;
Levy, Ronald .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (01) :239-244
[3]
BAHLER DW, 1991, BLOOD, V78, P1561
[4]
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [J].
Bendandi, M ;
Gocke, CD ;
Kobrin, CB ;
Benko, FA ;
Sternas, LA ;
Pennington, R ;
Watson, TM ;
Reynolds, CW ;
Gause, BL ;
Duffey, PL ;
Jaffe, ES ;
Creekmore, SP ;
Longo, DL ;
Kwak, LW .
NATURE MEDICINE, 1999, 5 (10) :1171-1177
[5]
Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: Specific immune responses despite profound immunosuppression [J].
Bertinetti, C ;
Zirlik, K ;
Heining-Mikesch, K ;
Ihorst, G ;
Dierbach, H ;
Waller, CF ;
Veelken, H .
CANCER RESEARCH, 2006, 66 (08) :4496-4502
[6]
Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli [J].
Bertinetti, Cristina ;
Simon, Frederic ;
Zirlik, Katja ;
Heining-Mikesch, Kristina ;
Pfeifer, Dietmar ;
Osterroth, Frank ;
Rosenthal, Felicia M. ;
Veelken, Hendrik .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) :395-402
[7]
Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions? [J].
Bogen, B. ;
Ruffini, P. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 70 (06) :526-530
[8]
DETERMINANT SELECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGENIC PEPTIDES IS EXPLAINED BY CLASS I-PEPTIDE AFFINITY AND IS STRONGLY INFLUENCED BY NONDOMINANT ANCHOR RESIDUES [J].
CHEN, WS ;
KHILKO, S ;
FECONDO, J ;
MARGULIES, DH ;
MCCLUSKEY, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1471-1483
[9]
CLUSTERING OF EXTENSIVE SOMATIC MUTATIONS IN THE VARIABLE REGION OF AN IMMUNOGLOBULIN HEAVY-CHAIN GENE FROM A HUMAN B-CELL LYMPHOMA [J].
CLEARY, ML ;
MEEKER, TC ;
LEVY, S ;
LEE, E ;
TRELA, M ;
SKLAR, J ;
LEVY, R .
CELL, 1986, 44 (01) :97-106
[10]
Dolken G, 1996, J CLIN ONCOL, V14, P1333